Status:
COMPLETED
Racial and Genetic Biomarkers of Response in Tissue Samples From Patients With Endometrial Cancer
Lead Sponsor:
Gynecologic Oncology Group
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Stage I Uterine Corpus Cancer
Stage II Uterine Corpus Cancer
Eligibility:
FEMALE
Brief Summary
This research study is studying racial and genetic biomarkers of response in tissue samples from patients with endometrial cancer. Studying samples of tissue from patients with cancer in the laborator...
Detailed Description
PRIMARY OBJECTIVES: I. To identify racial categorization as the proportion of genetic background of African-American or European-American women with endometrioid endometrial cancer (EEC). II. To eva...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Histologically confirmed endometrial cancer
- Stage I-IV disease regardless of grade
- Underwent surgical staging including hysterectomy, bilateral oophorectomy, washings, and pelvic lymphadenectomy
- Eligible and evaluated on GOG-0210 clinical trial, a Molecular Staging Study in Endometrial Cancer
- Available frozen or formalin-fixed and paraffin-embedded normal tissue that is free of tumor cells and yields sufficient high-quality normal DNA for testing
- Consented their specimens and clinical data to be collected and used in future studies
- Self-declared African-American or Caucasian race
Exclusion
Key Trial Info
Start Date :
January 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2017
Estimated Enrollment :
243 Patients enrolled
Trial Details
Trial ID
NCT01198171
Start Date
January 1 2010
End Date
February 1 2017
Last Update
August 14 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gynecologic Oncology Group
Philadelphia, Pennsylvania, United States, 19103